体外诊断试剂和细胞培养基市场规模、份额和成长分析：按产品类型、应用和地区划分－2026-2033年产业预测

2024年全球体外诊断和细胞培养基市场价值为828亿美元，预计将从2025年的862.8亿美元增长到2033年的1199.1亿美元。预测期（2026-2033年）的复合年增长率预计为4.2%。

体外诊断和细胞培养基市场的主要驱动力是日益增长的对准确、快速生物学数据的需求，这些数据对于指导临床决策和促进生物製药开发至关重要。该市场涵盖多种产品，例如指南、仪器和试剂，这些产品支持研发和生产过程中疾病生物标记的检测和细胞增殖。高诊断准确性可降低治疗的不确定性，而高品质的培养基则有助于生产可靠的生物製药。检测需求的成长和单株抗体生产的扩张都印证了这一点。精准医疗、细胞疗法和生物製药生产的融合正在为整个诊断和培养基供应链拓展机会。为了满足日益增长的单株抗体和疫苗生产需求，定製配方和一次性培养基形式的创新正在推动生产流程的优化和污染风险的降低。

全球体外诊断与细胞培养基市场驱动因素

全球体外诊断和细胞培养基市场的发展主要受生物製药公司研发管线扩张和开发活动的推动。这些公司在药物发现、筛检和生物製药生产等各个环节都需要可靠的检测方法和高品质的培养基，从而导致对先进解决方案的需求不断增长。因此，供应商正积极寻求配方创新并扩大生产规模，以提高产品的可用性和多样性。这种与研发需求的协同效应正在促进整个价值链的合作，并透过持续的采购和技术进步进一步加速市场成长。

全球体外诊断和细胞培养基市场的限制因素

由于法规结构复杂且不断演变，体外诊断试剂和细胞培养基的全球市场面临严峻挑战。这些法规带来了沉重的合规负担，可能阻碍产品上市并增加研发成本。製造商必须遵守各种区域标准，并证明产品的安全性、性能和质量，这减缓了创新速度，并阻碍了中小企业进入市场。此外，这些监管要求要求大量的文件和检验，使国际商业化更加复杂，减缓了新技术在实验室中的应用速度，儘管科学技术不断进步，但仍阻碍了整体市场成长。

体外诊断和细胞培养基的全球市场趋势

在全球体外诊断和细胞培养基市场，一个显着的趋势是人工智慧技术的整合，这些技术能够加速诊断并简化实验室工作流程。这些创新工具利用机器学习演算法进行检测设计和影像分析，从而加快诊断开发迭代速度并提高可重复性。复杂生物讯号与临床背景的整合正在加速预测性生物标记和自适应检测策略的出现，并提升其临床意义。此外，分析流程的自动化增强了资料管理和检验过程，促进了诊断试剂生产商、实验室和医疗服务提供者之间的协作，同时支援适用于分散式医疗的各种检测方法。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势
• 案例研究

全球体外诊断试剂和细胞培养基市场规模：按产品类型和复合年增长率划分（2026-2033 年）

• 体外诊断（IVD）
  • 感染疾病
  • 肿瘤学
  • 心血管疾病
  • 代谢性疾病
  • 免疫疾病
  • 其他的
• 细胞培养基
  • 生物製药生产
  • 药物发现与开发
  • 诊断
  • 再生医学
  • 其他的

全球体外诊断试剂和细胞培养基市场规模：按应用和复合年增长率划分（2026-2033 年）

• 体外诊断（IVD）
  • 感染疾病
  • 肿瘤学
  • 循环系统疾病
  • 代谢性疾病
  • 免疫疾病
  • 其他的
• 细胞培养基
  • 生物製药生产
  • 药物发现与开发
  • 诊断
  • 再生医学
  • 其他的
• 最终用户
  • 医院/诊断检查室
  • 製药和生物技术公司
  • 研究机构和学术机构
  • 其他的

全球体外诊断试剂及细胞培养基市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific
• Abbott Laboratories
• Roche Diagnostics
• BD（Becton, Dickinson and Company）
• Qiagen
• Agilent Technologies
• PerkinElmer
• Bio-Rad Laboratories
• Merck Group
• Siemens Healthineers
• Illumina
• Genomatix
• Promega Corporation
• Cell Signaling Technology
• Lonza Group
• Sigma-Aldrich
• Eppendorf
• Hologic
• 10X Genomics
• Sartorius AG

结论与建议

Global In Vitro Diagnostics And Cell Culture Medias Market size was valued at USD 82.8 Billion in 2024 and is poised to grow from USD 86.28 Billion in 2025 to USD 119.91 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The in vitro diagnostics and cell culture media market is primarily driven by the rising need for precise and rapid biological data, essential for guiding clinical decisions and enhancing biopharmaceutical development. This market includes a variety of products such as assays, instruments, and reagents that support disease biomarker detection and cell growth for research and manufacturing. Diagnostic accuracy reduces treatment uncertainties, while high-quality media facilitates dependable biologics production, evident from increased testing demands and monoclonal antibody manufacturing. The convergence of precision medicine, cell therapy, and biologics manufacturing broadens opportunities across diagnostics and media supply chains. Innovations in custom formulations and single-use media formats are emerging to meet the growing demands of monoclonal antibody and vaccine production, optimizing manufacturing processes and mitigating contamination risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Diagnostics And Cell Culture Medias market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Diagnostics And Cell Culture Medias Market Segments Analysis

Global in vitro diagnostics and cell culture medias market is segmented by product type, application and region. Based on product type, the market is segmented into In Vitro Diagnostics (IVD) and Cell Culture Media. Based on application, the market is segmented into In Vitro Diagnostics (IVD), Cell Culture Media and End User. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media is driven by the increasing expansion of research pipelines and development activities undertaken by biopharmaceutical companies. These firms require reliable assays and high-quality media for various processes such as discovery, screening, and biologics production, leading to a heightened demand for advanced solutions. As a result, suppliers are motivated to innovate formulations and scale up manufacturing, thereby improving product availability and diversity. This synergy between research and development needs fosters collaborative efforts throughout the value chain, further propelling market growth through ongoing procurement and technological advancements.

Restraints in the Global In Vitro Diagnostics And Cell Culture Medias Market

The global market for in vitro diagnostics and cell culture media faces notable challenges due to complex and evolving regulatory frameworks. These regulations impose significant compliance burdens that can hinder product introductions and inflate development costs. Manufacturers are required to navigate a variety of regional standards and demonstrate safety, performance, and quality, which can decelerate innovation and deter smaller companies from market participation. Additionally, these regulatory demands complicate international commercialization by necessitating extensive documentation and validation, ultimately slowing the pace at which new technologies become available in laboratories and hampering overall market growth, despite ongoing scientific advancements.

Market Trends of the Global In Vitro Diagnostics And Cell Culture Medias Market

The global in vitro diagnostics and cell culture media market is witnessing a significant trend towards the integration of AI-enabled technologies, which enhance diagnostic acceleration and streamline laboratory workflows. These innovative tools leverage machine learning algorithms for assay design and image interpretation, facilitating rapid iteration and increased reproducibility in diagnostic development. The synthesis of complex biological signals with clinical context is driving the emergence of predictive biomarkers and adaptive testing strategies, thereby amplifying clinical relevance. Additionally, automation in analytical pipelines is enhancing data curation and validation processes, fostering collaboration among diagnostics manufacturers, laboratories, and healthcare providers while enabling a wider range of assays suitable for decentralized care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Case Studies

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size by Application & CAGR (2026-2033)

• Market Overview
• In Vitro Diagnostics (IVD)
  • Infectious Diseases
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunological Disorders
  • Others
• Cell Culture Media
  • Biopharmaceutical Production
  • Drug Discovery & Development
  • Diagnostics
  • Regenerative Medicine
  • Others
• End User
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Others

Global In Vitro Diagnostics and Cell Culture Medias Market Size & CAGR (2026-2033)

• North America (Product Type, Application)
  • US
  • Canada
• Europe (Product Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10X Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations